Channel activity and subsequent access is determined by antenna selection. A sensing period is allocated into slots, dependent on the number of available antennas. For each slot, a distinct set of antennas is used for sensing for channel activity. Results of channel activity measurements for the slots are combined to form a channel activity report.

A system and method to use quick response (QR) codes encoded with merchant website t identification codes and session GUID to register a user or code scanner with a merchant server, login the user or code scanner with the merchant server, and complete a purchase of an item or service within a virtual shopping cart of the merchant server. A code scanner can scan a QR code displayed on a device connected to the internet. An application server can receive an identification code from the code scanner and then transmit data indicating form fields to be filled in on a merchant webpage. A user profile can include data regarding the user and a payment instrument. The user profile data can prepopulate the form fields and the form field data can be transmitted to the merchant server to use for logging in the user and completing the purchase.

A method for presenting an end user with the available actions for an item being dragged in a user interface shown on a screen of a computing device is disclosed. The method comprises the steps of (a) displaying the possible actions for an item as one or more drop targets when that item begins to be dragged, the drop targets being visually distinguishable on the screen from other regions or icons on the screen; (b) allowing the user to select an action by dropping the dragged item onto an associated drop target displayed in step (a) above. The drop targets are made visually distinguishable on the screen from other regions or icons on the screen by virtue of a change to what is shown on screen, and the change is triggered by the detection of the item being dragged.

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain pyridyl-amino-pyrazine carbonitrile compounds that, inter alia, inhibit Checkpoint Kinase 1 (CHK1) kinase function. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit CHK1 kinase function, and in the treatment of diseases and conditions that are mediated by CHK1, that are ameliorated by the inhibition of CHK1 kinase function, etc., including proliferative conditions such as cancer, etc., optionally in combination with another agent, for example, (a) a DNA topoisomerase I or II inhibitor; (b) a DNA damaging agent; (c) an antimetabolite or thymidylate synthase (TS) inhibitor; (d) a microtubule targeted agent; and (e) ionising radiation.

The present invention provides a method of detecting or measuring trans-Resveratrol (tRV) in a sample, comprising: contacting a sample to be tested with an antibody against tRV, or an antigen binding fragment of such an antibody; and detecting or measuring any tRV bound by the antibody or antibody fragment. The invention also provides an antibody against trans-Resveratrol.

The invention relates to a system for creating a market for selling products. The system comprises a first user input unit operable to receive one or more parameters from a first user, a configuration unit operable to configure a graph of price variation against time from parameters supplied by the first user input units, a graphic unit, configured to provide a graph or data for a graph of price variation against time to a second user, a current price display unit configured to calculate a current price from the graph and to display the current price to the second user, and a purchase unit configured to receive an instruction from the second user to purchase a product at the current price displayed by the current price display unit.

A code scanner (106) scans a quick response (QR) code that encodes a merchant identification codes assigned to a merchant that generates an invoice. The first invoice comprises invoice data. The code scanner decodes the QR code to recover the merchant identification code encoded within the QR code. The code scanner can display the invoice data and one or more selectable payment instruments. The code scanner selects a first payment instrument to pay the first invoice. The code scanner transmits, to an application server (102) for attempting to pay the invoice, the merchant identification code, data pertaining to the selected payment instrument, and at least a portion of the invoice data. The application server can attempt to pay the invoice and notify the code scanner whether the attempt to pay the invoice was successful. The code scanner can display notification that indicates whether attempt to pay the invoice was successful.

Benzimidazoles of formula (I): wherein: A is 5-to 12-membered aryl or 5-to 12-membered heteroaryl, each of which is unsubstituted or substituted; Y is a single bond, -(CH2)p-, -X-, -CH2-X-, or -X-CH2-; X is -O-, -S-, -N(R2)-, >C=O, >S(=O), >S(=O)2, -O-C(=O)-, -C(=O)-O-, N(R2)-C(=O)-, or -C(=O)-N(R2)-; each L is independently a single bond, C1-3alkylene, C2-3alkenylene or C2-3alkynylene; R1is C1-6alkyl, C2-6alkenyl or C2-6alkynyl, each of which is unsubstituted or substituted; each Z is independently -N(R2)2, -OR2, -SR2, -S(=O)R2, -S(=O)2R2; each R2 is independently hydrogen, C1-6alkyl, C2-6alkenyl or C2-6 alkynyl, wherein said alkyl, alkenyl and alkynyl groups are unsubstituted or substituted; m is 0, 1, 2, or 3; n is 1, 2, or 3; and p is 1, 2, or 3; and the pharmaceutically acceptable salt thereof are inhibitors of RSV and can therefore be used to treat or prevent an RSV infection.

The present invention provides a chromatography medium comprising one or more electrospun polymer nanofibres which form a stationary phase comprising a plurality of pores through which a mobile phase can permeate and use of the same in chromatography, such as the isolation of recombinant proteins, monoclonal antibodies, viral vaccines and plasmid DNA. The invention further provides for the use of the chromatographic medium in a simulated moving bed system.

A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.